Comparative effectiveness of alternative intervals between first and second doses of the mRNA COVID-19 vaccines
Description
The optimal interval between the first and second doses of COVID-19 mRNA vaccines has not been thoroughly evaluated. Employing a target trial emulation approach, we compared the effectiveness of different interdose intervals among >6 million mRNA